Abstract:Early-onset colorectal cancer (EO-CRC; defined as colorectal cancer [CRC] diagnosed in individuals younger than 50 years) has increased recently in the US. 1 Evidence has shown that patients living in impoverished and rural areas have an increased risk of CRC death, 2 ,3 but this has not been examined for EO-CRC. Thus, we examined the associations of EO-CRC mortality with persistent poverty, rurality, and the intersection of persistent poverty and rurality overall and within age groups. Data extracted for this study were publicly available and deidentified, and thus considered exempt from review by the institutional review board at Augusta University, and informed consent was not required. This study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline. Additional information can be found in the eAppendix in Supplement 1. We analyzed the 2006 to 2015 Incidence Data with Census Tract Attributes from Surveillance, Epidemiology, and End Results (SEER) Program. Cause-specific survival for CRC was the outcome of interest; deaths from other causes were censored. Census tract persistent poverty (yes or no) and rurality (yes or no) were our exposures of interest, with stratification by SEER age group (20 to 29 years, 30 to 39 years, and 40 to 49 years). Census tract persistent poverty was previously defined as 20% or more of the population living below the poverty level for a period spanning approximately 30 years. 4 Rurality was defined by US Department of Agriculture Rural Urban Commuting Area codes, with 4.0, 4.2, 5.0, 5.2, 6.0 to 7.0, 7.2 to 8.0, 8.2 to 10.0, and 10.2 to 10.6 considered as rural. 4 The Kaplan-Meier method with log-rank test and multivariable confounders (ie, patient demographics, year of diagnosis, tumor characteristics, initial treatment modality) adjusted Cox proportional hazards regression models were performed. Data were analyzed using SAS version 9.4 (SAS Software). Statistical significance was a 2-sided P < .05. Data were analyzed from February 15 to February 28, 2024. Among 58 200 patients with EO-CRC, 42 694 were aged 40 to 49 years (73%) and 30 580 (53%) were male. Among patients included in this study, 1346 patients (21%) lived in rural areas with persistent poverty. Overall, 5-year survival was highest for those living in nonpoverty and nonrural areas (46 566 [72%]) and lowest for those living in poverty areas regardless of rurality (6480 [67%]), with some variation by age group (eg, survival was 64% for those aged 20 to 29 years living in impoverished rural areas). In multivariable analysis, patients with EO-CRC who lived in rural areas alone had 1.1-fold to 1.4-fold increased risk of CRC death compared with those living in nonrural areas (20 to 29 years: hazard ratio [HR], 1.35; 95% CI, 1.06-1.71; 30 to 39 years: HR, 1.26; 95% CI, 1.13-1.41; 40 to 49 years: HR, 1.12; 95% CI, 1.06-1.19). Those living in both poverty and rural areas had a 1.1-fold to 1.5-fold increased risk of CRC death compared with those living in nonrural areas (overall: HR, 1.29; 95% CI, 1.18-1.42) with notably high estimates for that aged 30 to 39 years (HR, 1.51; 95% CI, 1.22-1.88) (Table). In this study, patients with EO-CRC living in rural areas had lower 5-year survival rates than their urban dwelling counterparts. While it was not observed consistently for all age groups, persistent poverty in these rural areas may compound this association. For example, 30 to 39-year-olds living in rural and impoverished areas had a 50% greater risk of CRC death than those living in other areas. This intersecting association with risk of CRC death was also more pronounced for patients with EO-CRC by 30% compared with 19% in average-onset CRC. Potential explanations for this association include patients with EO-CRC who lived in rural areas may have been diagnosed with later stage disease more frequently, 5 underinsurance among younger adults, especially in nonexpanded Medicaid states with high rurality, or lower quality treatment received by patients in rural or impoverished areas. 5 Other considerations may include higher levels of comorbidities (eg, obesity) among younger adults who lived in rural areas, which could complicate the likelihood of treatment success. 6 EO-CRC is a rising concern nationwide but underresourced areas face unique challenges. Our results can be used to inform health system policies for ongoing investments in cancer diagnosis and treatment resources in rural or impoverished areas for younger CRC patients and their communities. These may include education programs to encourage healthy lifestyles, and symptom awareness campaigns tailored to young adults to improve earlier diagnosis. This study is limited by the inability to adjust for other important confounders, such as lifestyle factors, comorbidities, a -Abstract Truncated-

Proximity to cancer rehabilitation and exercise oncology by geography, race, and socioeconomic status

Abstract 14253: Distance to Cardiac Rehabilitation is Associated With Participation and Completion

Abstract B053: Rural-urban disparities in cancer risk factors and screening by United States census region

Abstract 2160: Utilizing geospatial analytics to identify neighborhood cancer hot spots for recruitment of underserved populations in clinical prevention research

Abstract 797: Area deprivation, rurality, healthcare utilization, quality of life, and health status among cancer patients

Abstract B166: Impact of rurality on early-onset colorectal cancer outcomes: Age, geographic disparities, and the need for improved access and awareness in the United States

Residential Redlining, Neighborhood Trajectory, and Equity of Breast and Colorectal Cancer Care

Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time

Associations Between Oncology Outreach and Patient‐Sharing Measures of Care Coordination

Abstract B104: Identifying gaps in equitable cancer care: insights from US-based oncology professionals engaged in continuing medical education

How far is too far? Cancer prevention and clinical trial enrollment in geographically underserved patient populations

Abstract B135: Association of residential economic and racial segregation with metastatic disease at diagnosis in pediatric patients with solid tumors

Abstract PO3-27-08: Geographic Distribution and Accessibility of Clinical Trials for Advanced-Stage Breast Cancer in the United States: A Focus on Rural and Minority Health Disparities

Rural-Urban Disparities in Health Access Factors Over Time: Implications for Cancer Prevention and Health Equity in the Midwest

Evaluating Social Determinants of Health Related to Cancer Survivorship and Quality of Care

Exploring Demographic Differences and Outcomes in Early-Onset Colorectal Cancer

Abstract A051: Association of residential economic and racial segregation with pediatric cancer survival

Geographic access to cardiac rehabilitation and cardiovascular disease outcomes: A study of rural United States counties

Abstract B120: Understanding Barriers and Facilitators Affecting Participation in Cancer Clinical Research Studies for Racially and Ethnically Diverse Populations in Rural North Carolina

Intersection of Poverty, Rurality, and Early-Onset Colorectal Cancer Survival

Abstract A053: Assessing the impact of the COVID-19 pandemic on a statewide breast and cervical cancer safety net screening and diagnostic program: Are there differences by rural – urban geography?